# Advisor Review - GPT-5.4 (R1)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T21:44:16.953211
**Route:** OpenRouter + LaTeX
**Paper Hash:** 0daca880a7be87e0
**Tokens:** 19948 in / 1210 out
**Response SHA256:** 147abef6bf9fbd9f

---

I checked the paper for fatal errors in the four requested categories, with attention to every table and the timing/design logic.

Findings:

- **Data-design alignment:** No fatal timing mismatch. Treatment starts in **2019–2021** and outcome data cover **2001–2024**, so all cohorts are observed post-treatment. The placebo specification using pre-2019 data is also internally feasible.
- **Regression sanity:** No fatal regression-output problems found in any table. No impossible values, no NA/NaN/Inf, no negative SEs, no R² issues, and no implausibly huge coefficients/SEs.
- **Completeness:** Regression tables report sample sizes and uncertainty measures. No placeholder values or empty numeric cells found. Referenced tables/figures cited in the text do appear in the source.
- **Internal consistency:** The key numbers are internally consistent across abstract, main text, and tables:
  - Main ATT: **-0.3024 (0.0636)**
  - TWFE: **0.5866 (0.1666)**
  - Placebo: **0.4371 (0.0625)** in Appendix Table `tab:robustness`
  - Sample size: **57,840 observations = 2,410 municipalities × 24 years**
  - Pre-treatment summary counts also reconcile exactly:
    - Treated: **2,224 × 18 = 40,032**
    - Control: **186 × 18 = 3,348**

I do not see a fatal issue that would make the empirical design impossible, the tables broken, or the paper obviously incomplete.

ADVISOR VERDICT: PASS